{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:37:23Z","timestamp":1761928643627,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychosomatics"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1176\/appi.psy.44.2.120","type":"journal-article","created":{"date-parts":[[2003,3,4]],"date-time":"2003-03-04T17:33:04Z","timestamp":1046799184000},"page":"120-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["A Prospective Trial of Sustained-Release Bupropion for Depression in HIV-Seropositive and AIDS Patients"],"prefix":"10.1016","volume":"44","author":[{"given":"M.","family":"Beatriz Currier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"German","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1176\/appi.psy.44.2.120_bib0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archpsyc.1994.03950010039006","article-title":"WHO Neuropsychiatric AIDS Study, cross sectional phase I: study design and psychiatric findings","volume":"51","author":"Maj","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1176\/appi.psy.44.2.120_bib0010","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1001\/jama.1993.03510210049026","article-title":"Depressive symptoms as predictors of medical outcomes in HIV infection: Multicenter AIDS Cohort Study","volume":"270","author":"Lyketsos","year":"1993","journal-title":"JAMA"},{"key":"10.1176\/appi.psy.44.2.120_bib0015","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1001\/jama.1993.03510210054027","article-title":"Depressive symptoms and CD4 lymphocyte decline among HIV-infected men","volume":"270","author":"Burack","year":"1993","journal-title":"JAMA"},{"key":"10.1176\/appi.psy.44.2.120_bib0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1176\/ajp.156.1.101","article-title":"Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebocontrolled trial","volume":"156","author":"Rabkin","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1176\/appi.psy.44.2.120_bib0025","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1176\/ajp.151.4.516","article-title":"Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness","volume":"151","author":"Rabkin","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1176\/appi.psy.44.2.120_bib0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1176\/ajp.155.3.367","article-title":"Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients","volume":"155","author":"Elliott","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1176\/appi.psy.44.2.120_bib0035","first-page":"433","article-title":"Sertraline effects on mood and immune status in patients with major depression and HIV illness: an open trial","volume":"55","author":"Rabkin","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1176\/appi.psy.44.2.120_bib0040","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4088\/JCP.v60n0404","article-title":"Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone","volume":"60","author":"Elliott","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1176\/appi.psy.44.2.120_bib0045","first-page":"377","article-title":"Psychopharmacotherapy of psychiatric syndromes in asymptomatic and symptomatic HIV infections","volume":"9","author":"Fernandez","year":"1991","journal-title":"Psychiatr Med"},{"issue":"suppl 15","key":"10.1176\/appi.psy.44.2.120_bib0050","first-page":"19","article-title":"Drug interactions with newer antidepressants: role of human cytochrome P450","volume":"59","author":"Greenblatt","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1176\/appi.psy.44.2.120_bib0055","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1176\/ajp.153.3.311","article-title":"Newer antidepressants and the cytochrome P450 system","volume":"153","author":"Nemeroff","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.1176\/appi.psy.44.2.120_bib0060","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/ajhp\/57.4.376","article-title":"Depression in patients with HIV infection","volume":"57","author":"Penzak","year":"2000","journal-title":"Am J Health Syst Pharm"},{"key":"10.1176\/appi.psy.44.2.120_bib0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00002030-199401000-00010","article-title":"Cerebrospinal fluid dopamine in HIV-1 infections","volume":"8","author":"Berger","year":"1994","journal-title":"AIDS"},{"key":"10.1176\/appi.psy.44.2.120_bib0070","first-page":"2","article-title":"Mechanism of antidepressant activity of bupropion","volume":"11","author":"Ferris","year":"1993","journal-title":"J Clin Psychiatry Monogr"},{"key":"10.1176\/appi.psy.44.2.120_bib0075","first-page":"395","article-title":"Bupropion: a review of its mechanism of antidepressant activity","volume":"56","author":"Ascher","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1176\/appi.psy.44.2.120_bib0080","first-page":"513","article-title":"Pharmacokinetics of second-generation antidepressants: bupropion","volume":"27","author":"Goodnick","year":"1991","journal-title":"Psychopharmacol Bull"},{"unstructured":"Norvir (ritonavir) product instruction brochure. Chicago, Abbot Laboratories, 1995","key":"10.1176\/appi.psy.44.2.120_bib0085"},{"year":"1999","author":"Wellbutrin","series-title":"(bupropion SR) product information brochure","key":"10.1176\/appi.psy.44.2.120_bib0090"},{"key":"10.1176\/appi.psy.44.2.120_bib0095","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"key":"10.1176\/appi.psy.44.2.120_bib0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-Mental State\u201d: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1176\/appi.psy.44.2.120_bib0105","article-title":"Structured Clinical Interview for DSM-IV (SCID). New York, New York State Psychiatric Institute","author":"Spitzer","year":"1995","journal-title":"Biometrics Research"},{"key":"10.1176\/appi.psy.44.2.120_bib0110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archinte.158.3.247","article-title":"A critical assessment of the prognostic value of HIV-1 RNA levels and CD4 cell counts in HIV-infected patients: the Swiss HIV Cohort Study","volume":"158","author":"Yerly","year":"1998","journal-title":"Arch Intern Med"},{"unstructured":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41(RR-17):1\u201319","key":"10.1176\/appi.psy.44.2.120_bib0115"},{"key":"10.1176\/appi.psy.44.2.120_bib0120","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archpsyc.1988.01800320058007","article-title":"A structured interview guide for the Hamilton Depression Rating Scale","volume":"45","author":"Williams","year":"1988","journal-title":"Arch Gen Psychiatry"},{"year":"1976","first-page":"217","series-title":"ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76\u2013338","key":"10.1176\/appi.psy.44.2.120_bib0125"},{"year":"1985","author":"Reitan","series-title":"The Halstead-Reitan Neuropsychological Test Battery","key":"10.1176\/appi.psy.44.2.120_bib0130"},{"key":"10.1176\/appi.psy.44.2.120_bib0135","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/archneur.1990.00530040085022","article-title":"Cognition in early human immunodeficiency virus infection","volume":"47","author":"Wilkie","year":"1990","journal-title":"Arch Neurol"},{"issue":"suppl","key":"10.1176\/appi.psy.44.2.120_bib0140","first-page":"380","article-title":"Cerebrospinal fluid biogenic amine metabolism in patients with AIDS (abstract)","volume":"39","author":"Britton","year":"1989","journal-title":"Neurology"},{"key":"10.1176\/appi.psy.44.2.120_bib0145","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/jnr.490280313","article-title":"Cerebrospinal fluid catecholamine metabolites in HIV-1 infected patients","volume":"28","author":"Larrson","year":"1991","journal-title":"J Neurosci Res"},{"key":"10.1176\/appi.psy.44.2.120_bib0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0163-8343(96)00172-7","article-title":"Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS: improvements in affective and somatic symptoms","volume":"19","author":"Fernando","year":"1997","journal-title":"Gen Hospital Psychiatry"}],"container-title":["Psychosomatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318203703090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318203703090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:25:35Z","timestamp":1758500735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033318203703090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S0033318203703090"],"URL":"https:\/\/doi.org\/10.1176\/appi.psy.44.2.120","relation":{},"ISSN":["0033-3182"],"issn-type":[{"type":"print","value":"0033-3182"}],"subject":[],"published":{"date-parts":[[2003,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Prospective Trial of Sustained-Release Bupropion for Depression in HIV-Seropositive and AIDS Patients","name":"articletitle","label":"Article Title"},{"value":"Psychosomatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1176\/appi.psy.44.2.120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The Academy of Psychosomatic Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}